MFS
ENTA icon

MSI Financial Services’s Enanta Pharmaceuticals ENTA Stock Holding History

MSI Financial Services’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-75
Closed -$3K – 3880
2015
Q3 		$3K Hold
75
– – ﹤0.01% 2603
2015
Q2 		$3K Hold
75
– – ﹤0.01% 2626
2015
Q1 		$2K Hold
75
– – ﹤0.01% 2720
2014
Q4 		$4K Buy
+75
New +$3.36K ﹤0.01% 2195
2014
Q3 		– Sell
-250
Closed -$11K – 2662
2014
Q2 		$11K Buy
+250
New +$9.54K ﹤0.01% 1749

Other funds holding ENTA

ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

MSI Financial Services's ENTA Position: Q4 2015 in Review

MSI Financial Services sold out of Enanta Pharmaceuticals (ENTA) in Q4 2015, closing a stake of 75 shares — an estimated $3K sold.

MSI Financial Services first reported a position in ENTA in Q2 2014 and held it in 5 quarters. The position peaked at $11K in Q2 2014. 136 funds tracked by Wall St. Rank hold ENTA as of Q4 2015.

  • MSI Financial Services reported no remaining Enanta Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • MSI Financial Services sold 75 Enanta Pharmaceuticals shares in Q4 2015, an estimated $3K.
  • MSI Financial Services first reported a position in Enanta Pharmaceuticals in Q2 2014 and held it in 5 quarters.
  • MSI Financial Services's Enanta Pharmaceuticals position peaked at $11K in Q2 2014.
  • 136 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2015.

Based on MSI Financial Services's 13F filing for Q4 2015, filed 4 Feb 2016.